CellRight Technologies
Tissue Regenix Group is a pioneering international medical technology company focused on regenerative products. Their mission is to restore patient function and vitality, aiming to establish leadership in regenerative medicine through innovative platform technologies like dCELL® and BioRinse™. They operate globally with facilities in the UK, US, and Germany, and serve key clinical areas including orthopaedics, dental, and bio-surgery. The company emphasizes sustainability, innovation, and excellence, and has a strategic focus on supply, sales revenue, sustainability, and scale to drive growth and shareholder value.
Industries
Nr. of Employees
small (1-50)
CellRight Technologies
Universal City, Texas, United States, North America
Products
Decellularised dermal implants (room-temperature format)
Soft-tissue implants produced by decellularisation and provided in a room-temperature stable format for soft tissue repair and reconstruction.
Sterile allograft bone matrices with preserved growth factors
Processed bone graft materials designed to retain native bone growth factors and deliver osteoinductive properties for spine, foot/ankle, dental and orthopaedic applications.
Porcine-derived xenograft implants
Xenograft tissue implants manufactured from porcine sources for orthopaedic and surgical device applications.
Birth-tissue (amnion) products for ocular and wound applications
Birth-tissue-derived products intended as barriers and coverings for ophthalmology and wound healing use-cases.
Decellularised dermal implants (room-temperature format)
Soft-tissue implants produced by decellularisation and provided in a room-temperature stable format for soft tissue repair and reconstruction.
Sterile allograft bone matrices with preserved growth factors
Processed bone graft materials designed to retain native bone growth factors and deliver osteoinductive properties for spine, foot/ankle, dental and orthopaedic applications.
Porcine-derived xenograft implants
Xenograft tissue implants manufactured from porcine sources for orthopaedic and surgical device applications.
Birth-tissue (amnion) products for ocular and wound applications
Birth-tissue-derived products intended as barriers and coverings for ophthalmology and wound healing use-cases.
Services
Processing and manufacture of sterile allograft bone matrices, decellularised dermal scaffolds and porcine-derived xenograft implants for surgical applications.
Donor sourcing, medical review, tissue retrieval and distribution services, including released donor tissue provision to other processors.
Maintenance of regulatory registrations, management of accreditations and implementation of ISO 13485-compliant quality management systems to support market access.
Research and development activities including feasibility studies, product design, process optimisation, verification/validation and clinical evidence generation.
Development of distributor networks, licensing agreements, GPO arrangements and strategic partnerships to support market expansion.
Processing and manufacture of sterile allograft bone matrices, decellularised dermal scaffolds and porcine-derived xenograft implants for surgical applications.
Donor sourcing, medical review, tissue retrieval and distribution services, including released donor tissue provision to other processors.
Maintenance of regulatory registrations, management of accreditations and implementation of ISO 13485-compliant quality management systems to support market access.
Research and development activities including feasibility studies, product design, process optimisation, verification/validation and clinical evidence generation.
Development of distributor networks, licensing agreements, GPO arrangements and strategic partnerships to support market expansion.
Expertise Areas
- Regenerative medicine
- Soft-tissue decellularisation and scaffold development
- Allograft bone processing and osteoinduction
- Xenograft device manufacturing
Key Technologies
- Soft-tissue decellularisation
- Allograft bone processing (osteoconductive/osteoinductive matrices)
- Porcine xenograft processing
- Multi-tissue banking and retrieval
News & Updates
Download the latest annual report of Tissue Regenix Group.
Download the latest annual report of Tissue Regenix Group.